Sign in / Join Now
ETFs & Funds
is making a big event and webcast wednesday after hours, should be exciting. i'm expecting positive results.
Add a reply...
Latest StockTalks »
people get CLDX breaking news and analysis by email alert.
Get email alerts on CLDX »
Celldex Therapeutics, Inc
Get latest price
From other sites
Phase 2 Study Of Single-agent Glembatumumab Vedotin In Patients With Checkpoint-Refractory Metastatic Melanoma Meets Primary Overall Response Endpoint And Demonstrates Clinically Meaningful Duration Of Response
at TheStreet (Oct 9, 2016)
Celldex Therapeutics To Present At The Leerink Partners Rare Disease & Immuno-Oncology Roundtable
at TheStreet (Sep 23, 2016)
Celldex Therapeutics Remains a Guessing Game
at Investopedia (Sep 20, 2016)
Celldex Appoints Elizabeth Crowley As Chief Product Development Officer
at TheStreet (Aug 11, 2016)
Celldex Therapeutics (CLDX) Stock Up on Q2 Results
at TheStreet (Aug 9, 2016)